Targeted RNA Degradation as a Promising Therapeutic Strategy
International Journal of Molecular Sciences · 05.11.2025 · 26 (21) · 10767
DOI: 10.3390/ijms262110767 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 05.11.2025. Verfasst von Sivakumar Komachankandy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, Pusan National University, Busan 46241, Republic of Korea. Hauptthemen laut MEDLINE: RNA Stability, RNA. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korea Basic Science Institute.
Abstract (Originalsprache)
RNAs have recently emerged as versatile therapeutic targets, broadening the scope of drug discovery beyond the conventional protein-centered paradigm. Small-molecule-induced RNA degradation has been established as a promising approach, with novel modalities such as Ribonuclease-Targeting Chimeras (RIBOTACs), bleomycin-conjugated degraders, and imidazole-based RNA degrader demonstrating strong potential. These strategies selectively eliminate disease-associated RNAs by harnessing endogenous ribonucleases, redirecting the nucleic acid-cleaving activity of natural products, or incorporating catalytic warheads. Recent studies have validated therapeutic applications across cancer, neurodegenerative disorders, and viral infections, underscoring the wide-ranging impact of this strategy. Nevertheless, key challenges remain, including the development of more potent recruiters, diversification of degradation mechanisms, optimization of linker chemistry, and overcoming pharmacokinetic limitations. With continued innovation, RNA degraders are expected to evolve into a robust therapeutic platform that expands the druggable space and enables new treatment opportunities for diseases once considered untreatable.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, Pusan National University, Busan 46241, Republic of Korea.
- Institute for Future Earth, Pusan National University, Busan 46241, Republic of Korea.
ORCID-Profile: Sivakumar Komachankandy
Förderung
- National Research Foundation of Korea
- Korea Basic Science Institute
Zitieren
APA
Komachankandy, S., & Lee, Y. (2025). Targeted RNA Degradation as a Promising Therapeutic Strategy. International Journal of Molecular Sciences, 26(21), 10767. https://doi.org/10.3390/ijms262110767
Vancouver
Komachankandy S, Lee Y. Targeted RNA Degradation as a Promising Therapeutic Strategy. International Journal of Molecular Sciences. 2025;26(21):10767. doi:10.3390/ijms262110767
BibTeX
@article{Komachankandy2025,
author = {Komachankandy, Sivakumar and Lee, Yeongju},
title = {Targeted RNA Degradation as a Promising Therapeutic Strategy},
journal = {International Journal of Molecular Sciences},
year = {2025},
volume = {26},
number = {21},
pages = {10767},
doi = {10.3390/ijms262110767}
}
EUVIMED